In our previous study, we carried out a meta-analysis of the data from publicly available repositories, whereby we selected two genes that show selectivity towards glioblastoma: those for FRAS1-related extracellular matrix protein 2, FREM2, and sprouty RTK signaling antagonist 1, SPRY1 [35]. The gene discussed is FREM2; the disease is glioblastoma.